Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients

BACKGROUND: Direct oral anticoagulants (DOACs) have been developed for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). We conducted a retrospective cohort study of patients with NVAF who were newly treated with DOACs in a real-world clinical setting. METHODS: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Umei, Masahiko, Kishi, Mikio, Sato, Takahiro, Shindo, Akito, Toyoda, Masayuki, Yokoyama, Masaaki, Matsushita, Masashiro, Ohnishi, Satoshi, Yamasaki, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634680/
https://www.ncbi.nlm.nih.gov/pubmed/29021853
http://dx.doi.org/10.1016/j.joa.2017.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634680/
https://www.ncbi.nlm.nih.gov/pubmed/29021853
http://dx.doi.org/10.1016/j.joa.2017.05.008

Ejemplares similares